Skip to main content
Bulletin of the World Health Organization logoLink to Bulletin of the World Health Organization
. 1968;39(5):775–779.

Toxicity of pyrazinamide, administered once weekly in high dosage, in tuberculous patients*

C V Ramakrishnan, B Janardhanam, D V Krishnamurthy, H Stott, S Subbammal, S P Tripathy
PMCID: PMC2554433  PMID: 5306313

Abstract

The success of a twice-weekly regimen of streptomycin plus isoniazid, reported earlier from the Tuberculosis Chemotherapy Centre, Madras, prompted an investigation at the Centre of various once-weekly regimens of chemotherapy. In this context, a pilot study was undertaken in 19 patients to assess the toxicity of high-dosage pyrazinamide (70 mg/kg of body-weight), when administered once weekly, together with isoniazid (14 mg/kg of body-weight) and streptomycin (1 g), for at least 6 months. Serial estimations of SGOT and SGPT activity, urine tests for urobilin and bilirubin and haematological investigations were undertaken at frequent intervals. None of the patients showed any clinical evidence of hepatotoxicity; however, there was a slight and transient elevation in aminotransferase activity, probably of a non-specific nature, at 2 weeks. These findings are encouraging for the use of high-dosage pyrazinamide in once-weekly regimens of chemotherapy.

Full text

PDF
779

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALLISON S. T. Pyrazinamide in low dosage in combination with isoniazid or paraaminosalicylic acid in the treatment of pulmonary tuberculosis. Am Rev Tuberc. 1959 Jan;79(1):102–104. doi: 10.1164/artpd.1959.79.1.102. [DOI] [PubMed] [Google Scholar]
  2. McDERMOTT W., ORMOND L., MUSCHENHEIM C., DEUSCHLE K., McCUNE R. M., Jr, TOMPSETT R. Pyrazinamide-isoniazid in tuberculosis. Am Rev Tuberc. 1954 Mar;69(3):319–333. doi: 10.1164/art.1954.69.3.319. [DOI] [PubMed] [Google Scholar]
  3. Nazareth O., Devadatta S., Evans C., Fox W., Janardhanam B., Menon N. K., Radhakrishna S., Ramakrishnan C. V., Stott H., Tripathy S. P. A two-year follow-up of patients with quiescent pulmonary tuberculosis following a year of chemotherapy with an intermittent (twice-weekly) regimen of isoniazid plus streptomycin or a daily regimen of isoniazid plus PAS. Tubercle. 1966 Jun;47(2):178–189. doi: 10.1016/s0041-3879(66)80034-x. [DOI] [PubMed] [Google Scholar]
  4. SOBOTKA H., LUISADA-OPPER A. V., REINER M. A new test for bilirubin in urine. Am J Clin Pathol. 1953 Jun;23(6):607–609. [PubMed] [Google Scholar]
  5. Sherlock S. Disease of the digestive system. Drugs and the liver. Br Med J. 1968 Jan 27;1(5586):227–229. doi: 10.1136/bmj.1.5586.227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. VELU S., ANDREWS R. H., ANGEL J. H., DEVADATTA S., FOX W., JACOB P. G., NAIR C. N., RAMAKRISHNAN C. V. Streptomycin plus pyrazinamide in the treatment of patients excreting isonazid-resistant tubercle bacilli, following previous chemotherapy. Tubercle. 1961 Jun;42:136–147. doi: 10.1016/s0041-3879(61)80089-5. [DOI] [PubMed] [Google Scholar]

Articles from Bulletin of the World Health Organization are provided here courtesy of World Health Organization

RESOURCES